Vialing of Monoclonal Antibody

Agency: COMMERCE, DEPARTMENT OF
State: Maryland
Type of Government: Federal
FSC Category:
  • A - Research and development
NAICS Category:
  • 561910 - Packaging and Labeling Services
Posted Date: Aug 13, 2025
Due Date: Sep 5, 2025
Solicitation No: NB645030-25-01699
Original Source: Please Login to View Page
Contact information: Please Login to View Page
Bid Documents: Please Login to View Page

Description

Follow
Vialing of Monoclonal Antibody
Active
Contract Opportunity
Notice ID
NB645030-25-01699
Related Notice
NB645030-25-01699
Department/Ind. Agency
COMMERCE, DEPARTMENT OF
Sub-tier
NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY
Office
DEPT OF COMMERCE NIST
Looking for contract opportunity help?

APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.

APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.

The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).

General Information
  • Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
  • Original Published Date: Aug 13, 2025 03:57 pm MDT
  • Original Date Offers Due: Sep 05, 2025 03:00 pm MDT
  • Inactive Policy: 15 days after date offers due
  • Original Inactive Date: Sep 20, 2025
  • Initiative:
    • None
Classification
  • Original Set Aside:
  • Product Service Code: AJ12 - GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH
  • NAICS Code:
    • 561910 - Packaging and Labeling Services
  • Place of Performance:
    Gaithersburg , MD 20899
    USA
Description

This solicitation is being issued as a Request for Quotation (RFQ). All communications and documents must include the solicitation number NB645030-25-01699. The contracting officer will not use, nor this solicitation be subject to the formal source selection procedures described in FAR Part 15. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2025-05.



The National Institute of Standards and Technology (NIST), Acquisition Management Division (AMD), Team E-Boulder has a requirement for Gaithersburg for Monoclonal Antibody Reference Material Vialing in accordance with the Statement of Work and RFQ documents.


Attachments/Links
Contact Information
Contracting Office Address
  • ACQUISITION MANAGEMENT DIVISION 100 BUREAU DR.
  • GAITHERSBURG , MD 20899
  • USA
Primary Point of Contact
Secondary Point of Contact


History

Related Document

Jun 23, 2025[Sources Sought (Original)] Sources Sought Contract Vialing of Monoclonal Antibody
Jul 3, 2025[Sources Sought (Updated)] Sources Sought Contract Vialing of Monoclonal Antibody
Aug 18, 2025[Combined Synopsis/Solicitation (Updated)] Vialing of Monoclonal Antibody
Aug 26, 2025[Combined Synopsis/Solicitation (Updated)] Vialing of Monoclonal Antibody
Get Government Bids Like This by Email Receive daily bid alerts that match your keywords, business categories, and target regions.

See Also

Follow Request for Information (RFI) on Identifying Basic Research Challenges to Accelerate United

ENERGY, DEPARTMENT OF

Due by 10/15/2026

Follow Broad Agency Announcement DEVCOM C5ISR ESI Active Contract Opportunity Notice ID Related

DEPT OF DEFENSE

Due by 10/31/2027

Follow Broad Agency Announcement DEVCOM C5ISR RTI Active Contract Opportunity Notice ID W56KGU23RRTID

DEPT OF DEFENSE

Due by 10/31/2027

Follow BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT

DEPT OF DEFENSE

Due by 6/11/2027

* Disclaimer: This website provides information about bids, requests for proposals (RFPs), or requests for qualifications (RFQs) for convenience only and does not serve as an official public notice. Individuals who wish to respond to or inquire about bids, RFPs, or RFQs should contact the relevant government department directly.